Current Hematologic Malignancy Reports

, Volume 9, Issue 2, pp 109–117

Novel Therapeutics in Acute Myeloid Leukemia

Acute Leukemias (F Ravandi, Section Editor)

DOI: 10.1007/s11899-014-0199-0

Cite this article as:
Sweet, K. & Lancet, J.E. Curr Hematol Malig Rep (2014) 9: 109. doi:10.1007/s11899-014-0199-0


Acute myeloid leukemia (AML) is a heterogenous disease, and the standard treatment with cytotoxic chemotherapy has remained largely unchanged for over four decades. As more is being learned about AML and the potential molecular targets found within the leukemia cells, an abundance of targeted therapies are becoming available for study in the treatment of this challenging disease. This review serves to provide a brief overview of some of several agents currently being studied and developed in AML.


Acute myeloid leukemiaCytotoxic chemotherapyNovel therapeuticsPharmacokinetically advantageous broad cytotoxicsHeterogeneity

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.TampaUSA